Cargando…
SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a recent advancement in the treatment of cystic fibrosis and were initially approved for their beneficial effect on lung function. There have also been few reports of their positive role in glycemic contro...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552780/ http://dx.doi.org/10.1210/js.2019-SUN-LB026 |